We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Human Papillomavirus

Department of Health and Social Care written question – answered on 27th June 2018.

Alert me about debates like this

Photo of The Countess of Mar The Countess of Mar Deputy Chairman of Committees, Deputy Speaker (Lords)

To ask Her Majesty's Government whether the strain of human papilloma virus (HPV) is tested for when an HPV infection is found in women who were offered HPV vaccination; and if so, what were the rates of the different strains found in women who were (1) 13–18 years old, and (2) older than 18.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

Human papillomavirus (HPV) testing is performed on specimens collected from some women attending for cervical screening as part of the NHS Cervical Screening Programme (women with borderline or low grade abnormalities, and women in areas piloting HPV primary testing). This test identifies if a high-risk HPV infection is present, but does not identify all the specific HPV types which are present.

Public Health England has also been monitoring the prevalence of type-specific genital HPV infections through surveys that use specimens from 16-24-year-old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, has shown a clear reduction in the two high-risk HPV types included in the vaccine and in some other closely related HPV types not included in the vaccine among women aged 16-18 years old. Declines were also seen in women aged 19-21 years old. The prevalence of other high-risk HPV types has not changed.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.